Icahn School of Medicine at Mount Sinai Awarded $10.2 Million NIH Grant to Explore the Early Signs of Arrhythmic Mitral Valve Prolapse
https://reachmd.com/news/icahn-school-of-medicine-at-mount-sinai-awarded-102-million-nih-grant-to-explore-the-early-signs-of-arrhythmic-mitral-valve-prolapse/2452628/
New York, NY (September 26, 2023) Researchers at the Icahn School of Medicine at Mount Sinai have been awarded a $10.2 million grant from the National Heart, Lung and Blood Institute of the National Instit…
NCCN Senior Director Evelyn Handel Zapata Is Named a '40 Under 40 in Cancer: Emerging Leader' for Milestone Work Improving Safe Use of Chemotherapy
https://reachmd.com/news/nccn-senior-director-evelyn-handel-zapata-is-named-a-40-under-40-in-cancer-emerging-leader-for-milestone-work-improving-safe-use-of-chemotherapy/2452627/
Dr. Handel Zapata oversees the NCCN Chemotherapy Order Templates program, which is marking 15 years of sharing evidence-based drug delivery information and just published new resources for children's cancer.PLYMOUTH MEETING, Pa., Sept. 25, 2023 /PRNewswire/ -- Evelyn Handel Zapata, PharmD, BCPS, B…
Researchers Uncover Why a Gene Mutant Causes Young Children to Have Strokes
https://reachmd.com/news/researchers-uncover-why-a-gene-mutant-causes-young-children-to-have-strokes/2452638/
A discovery of a mutation in the gene ACTA2 has given researchers, led by Dianna Milewicz, MD, PhD, with UTHealth Houston, insight into understanding the cause of a rare and progressive problem with arteries in the brain and a cause of strokes in young children, called moyamoya disease. The findin…
SARS-CoV-2 Infects Coronary Arteries, Increases Plaque Inflammation
https://reachmd.com/news/sars-cov-2-infects-coronary-arteries-increases-plaque-inflammation/2452631/
News ReleaseThursday, September 28, 2023SARS-CoV-2 infects coronary arteries, increases plaque inflammation NIH-funded research sheds light on link between COVID-19 infection and increased risk of cardiovascular disease and stroke.SARS-CoV-2, the virus that causes COVID-19, can directly infe…
US Surgeons Are Killing Themselves at an Alarming Rate. One Decided To Speak Out
https://reachmd.com/news/us-surgeons-are-killing-themselves-at-an-alarming-rate-one-decided-to-speak-out/2452619/
Carrie Cunningham puffed out her cheeks and exhaled. She looked out at the audience filled with 2,000 of her peers, surgeons who were attending the annual meeting of the Association of Academic Surgery, a prestigious gathering of specialists from universities across the United States and Canada. …
Researchers Combat Zika-Associated Fetal Abnormalities Using MicroRNA
https://reachmd.com/news/researchers-combat-zika-associated-fetal-abnormalities-using-microrna/2452616/
Zika virus (purple) seen under magnification. Credit: CDC / Cynthia Goldsmith Before SARS-CoV-2 and COVID-19, there was the Zika virus epidemic, lasting from 2015 to 2016. The Zika virus can cause serious birth defects and abnormalities. During the epidemic, one of the most striking results…
New Treatment Trialed in Mice Offers Hope for Advanced Liver Cancer
https://reachmd.com/news/new-treatment-trialed-in-mice-offers-hope-for-advanced-liver-cancer/2452609/
CD5-2 treatment improved tumor vessels structure. Representative scanning electron microscopy images of liver tumor blood vessels in the different treatment groups. Qualitatively, tumor blood vessels appeared to be more regula…
How Inverse Vaccines Might Tackle Diseases Like Multiple Sclerosis
https://reachmd.com/news/how-inverse-vaccines-might-tackle-diseases-like-multiple-sclerosis/2452610/
These immune-dampening shots could lead to a whole host of therapies to treat autoimmune diseases. In fact, Anokion, a company Hubbell cofounded, has already launched clinical trials to test whether this type of inverse vaccine might help people with multiple sclerosis and celiac disease. It’s an…
Genetics May Signal Risk of Hard to Find Ovarian Cancer
https://reachmd.com/news/genetics-may-signal-risk-of-hard-to-find-ovarian-cancer/2452612/
September is observed as ovarian cancer awareness month. It is the third most common cancer in women worldwide and nearly 20,000 women are newly diagnosed every year worldwide Image for representational purposes only. Photo Courtesy: iStock …
Clinical Trial to Test Immune Modulation Strategy for Hospitalized COVD-19 Patients Begins
https://reachmd.com/news/clinical-trial-to-test-immune-modulation-strategy-for-hospitalized-covd-19-patients-begins/2452600/
News Release Friday, September 22, 2023 Clinical trial to test immune modulation strategy for hospitalized covid-19 patients begins Part of NIH’s STRIVE consortium, the therapeutic may prevent overactive immune systems from causing severe symptoms. A clinical trial has launched to test whether ea…